A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Participants (18 to 70 Years of Age)
for Lyme Disease
Sponsor: ModernaTX, Inc.
Sex: All·Age: 18 - 70·Accepts healthy volunteers
Code: NCT07561294·Phase 2·Recruiting